Detalhe da pesquisa
1.
Data-driven modelling of neurodegenerative disease progression: thinking outside the black box.
Nat Rev Neurosci
; 25(2): 111-130, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191721
2.
Prognostic value of single-subject grey matter networks in early multiple sclerosis.
Brain
; 147(1): 135-146, 2024 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37642541
3.
Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome.
Brain
; 147(4): 1206-1215, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38085047
4.
Assessing brain involvement in Fabry disease with deep learning and the brain-age paradigm.
Hum Brain Mapp
; 45(5): e26599, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38520360
5.
Brain Tumor Imaging without Gadolinium-based Contrast Agents: Feasible or Fantasy?
Radiology
; 310(2): e230793, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38319162
6.
Rates of cortical thinning in Alzheimer's disease signature regions associate with vascular burden but not with ß-amyloid status in cognitively normal adults at age 70.
J Neurol Neurosurg Psychiatry
; 2024 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38199813
7.
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS).
J Neurol Neurosurg Psychiatry
; 95(5): 392-400, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37963723
8.
Impact of simulated reduced injected dose on the assessment of amyloid PET scans.
Eur J Nucl Med Mol Imaging
; 51(3): 734-748, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37897616
9.
Disease progression in the first 5 years of treatment in multiple sclerosis: Predictive value of early brain and lesion volume changes.
Mult Scler
; 30(1): 44-54, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38018502
10.
Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis.
Mult Scler
; 30(2): 266-271, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38235514
11.
Improving explanation of motor disability with diffusion-based graph metrics at onset of the first demyelinating event.
Mult Scler
; : 13524585241247785, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38751221
12.
Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease.
Mult Scler
; 30(6): 674-686, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38646958
13.
Treatment reduces the incidence of newly appearing multiple sclerosis lesions evolving into chronic active, slowly expanding lesions: A retrospective analysis.
Eur J Neurol
; 31(1): e16092, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37823722
14.
Visual associative learning to detect early episodic memory deficits and distinguish Alzheimer's disease from other types of dementia.
J Int Neuropsychol Soc
; : 1-10, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38389489
15.
Updating the study protocol: Insight 46 - a longitudinal neuroscience sub-study of the MRC National Survey of Health and Development - phases 2 and 3.
BMC Neurol
; 24(1): 40, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263061
16.
A data-driven study of Alzheimer's disease related amyloid and tau pathology progression.
Brain
; 146(12): 4935-4948, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433038
17.
Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis.
Brain
; 146(9): 3719-3734, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36967222
18.
Genetically identical twin-pair difference models support the amyloid cascade hypothesis.
Brain
; 146(9): 3735-3746, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36892415
19.
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.
Brain
; 146(6): 2489-2501, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36515653
20.
A systematic review of (semi-)automatic quality control of T1-weighted MRI scans.
Neuroradiology
; 66(1): 31-42, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38047983